Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
ConclusionsEarly CRP response at 4 weeks is predictive of survival for patients with mRCC treated with TKI.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research